What is the Current Share Price of Mercury Laboratories Ltd?
- Answer Field
-
Mercury Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 808.00 as on Mar 25 2026 03:30 PM.
As of the latest trading session, Mercury Laboratories Limited share price is currently at ₹811, which is down by ₹-44.00 from its previous closing. Today, the stock has fluctuated between ₹809.95 and ₹811.00. Over the past year, Mercury Laboratories Limited has achieved a return of -4.98%. In the last month alone, the return has been [-]%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 18.35 |
| Operating Expense | 16.84 |
| Net Profit | 1.00 |
| Net Profit Margin (%) | 5.44 |
| Earnings Per Share (EPS) | 8.31 |
| EBITDA | 2.44 |
| Effective Tax Rate (%) | 30.06 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.41 | 12.30 | 1.47 | 217.72 | 23.12 | 42.00 |
| BLISS GVS PHARMA LTD | 201.65 | 19.28 | 1.88 | 2133.23 | 105.05 | 244.05 |
| CIPLA LTD | 1298.80 | 22.07 | 3.18 | 104914.55 | 1283.00 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 339.00 | 11.28 | 2.55 | 997.71 | 241.30 | 399.00 |
| GLAXOSMITHKLINE PHARMACEUTICAL | 2405.15 | 40.51 | 23.85 | 40744.69 | 2220.00 | 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.41 | 27.32 | 3.96 | 217.72 | 23.12 | 42.00 |
| AMRUTANJAN HEALTH CARE LTD. | 528.05 | 26.40 | 4.46 | 1526.63 | 522.15 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8358.20 | 100.45 | 26.15 | 20895.50 | 6501.60 | 10653.05 |
| BLISS GVS PHARMA LTD | 201.65 | 27.47 | 1.93 | 2133.23 | 105.05 | 244.05 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, it converted into Private Limited Company & incorporated in February, 1982. Later, it converted into Limited Company in 1992 in Maharashtra. The Company has obtained ISO 9001:2008 registrations. It is engaged into the manufacturing and export of wide range of Pharmaceutical items. The Company products have been in Gynae and Pediatrics Segment. It is mainly dedicated to Mother & Child Healthcare.
Two new products launched in Ergacap Division in 2012-13. The Company introduced new drugs such as Teclobet, Tanolite, Clinzit, Clinzita-A, Levotryl Tablet, Levotryl-M Tablet, Levotryl Syrup, THA-4, THA-8, Pyloryl, Pangs At, Feveryl Drops, Feveryl Suspension in its Mother Child Care specialized segment. It further established Institutional Business with Govt. Institutions, Semi Government and Hospitals & Clinics in 2014-15.
The Company launched new world class GMP facility for all its liquids and tablets conforming requirement of WHO in 2015-16. It also has increased the manufacturing capacity for tablets and liquids in 2023-24.
Mercury Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 808.00 as on Mar 25 2026 03:30 PM.
The market cap of Mercury Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 97.00 as on Mar 25 2026 03:30 PM.
The 52 Week High and Low of Mercury Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 976.00 and ₹ 770.00.
The 1 year returns on the stock has been -4.98%.
As on Mar 25 2026 03:30 PM the price-to-earnings (PE) ratio for Mercury Laboratories Ltd share is 20.35.
As on Mar 25 2026 03:30 PM, the price-to-book (PB) ratio for Mercury Laboratories Ltd share is 464.65.
You can trade in Mercury Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Mercury Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Mercury Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found